Albemarle Corporation (ALB) Stock: Price, Forecast & Analyst Target
Albemarle Corporation (ALB) — MoonshotScore 72/100 (Strong band), calculated Nov 18, 2026. Price $82.93 (-3.37%), as of the Nov 19, 2026 trading session; market cap $9.79B. Expected results Feb 10, 2027.
Educational signal · not a buy or sell recommendation · How to read this
Market value / cash and short-term investments: 5.30× (cash as of Sep 30, 2026) · expected results Feb 10, 2027
Albemarle Corporation · ALB · NYSE · Basic Materials · Chemicals Specialty
Research dated 2026-09-13 (results through the quarter ended Jun 2026; the quarter ended Sep 2026 not covered): Albemarle Corporation supplies lithium compounds for batteries and industrial uses, bromine-based chemicals, and catalysts for petroleum refining and chemical production. Energy Storage is its largest reported business, making the durability of the recent profit and cash-flow rebound the defining issue. Can that rebound hold when management expects sequentially lower sales and EBITDA?
Price as of Nov 19, 2026
Key Statistics
MoonshotScore v2 · Albemarle (ALB)
StrongWhy this rating? Method, drivers & history
Bands for the MoonshotScore: Exceptional 80-100 · Strong 65-79 · Fair 45-64 · Weak below 45.
- Business Quality — Is this a genuinely good business?
- Financial Safety — Could this blow up on me?
- Valuation — Am I paying a fair price?
- Growth Durability — Is the growth real and likely to last?
- Momentum — Is the market already moving on this?
High quality, a strong balance sheet and durable growth, at a cheap price, with no real weak spot, and the price trend has turned against it. Business Quality: Solid; Financial Safety: Sound; Valuation: Cheap; Growth Durability: Growing; Momentum: Slipping.
- EPS beat 6 of the last 8 reports
- expected results Feb 10, 2027
- Altman Z 2.37 · Piotroski F 8
Holding back: weak price trend
Helping: business quality, balance-sheet strength, an attractive price, durable growth
What has the MoonshotScore done over time?
| Recorded | Score | Band |
|---|---|---|
| 70 | Strong | |
| 70 | Strong | |
| 70 | Strong | |
| 72 | Strong | |
| 72 | Strong | |
| 72 | Strong |
Daily score refresh is delayed. This is the last recorded calculation.
Calculation uses the most recent completed US trading session. Live price changes do not update the score immediately.
Computed · How the MoonshotScore is computed →
Price & valuation
| Measure | Value | As of |
|---|---|---|
| Latest provided price | $82.93 | |
| Change on the day | -3.37% | |
| 52-week range | $82.93–$221.00 | |
| Market capitalisation | $9.79B | — |
| Price / earnings (trailing) | 20.11 | |
| Shares traded on the day | 2.20M | |
| Beta (volatility vs the S&P 500) | 1.36 | |
| Dividends per share (last 12 months) | $1.63 | |
| Dividend yield (last 12 months) | 1.85% |
Why Albemarle scores 72
Share price, last 12 months -7.6%
$103.88 $95.97
What the price assumes
-5.8% a year of free-cash-flow growth for ten years is what a $11.33B market value ( snapshot) asks for.
The price asks for less growth than the business has been producing. The question it leaves open is how long that pace lasts, not whether it exists.
Reverse discounted cash flow: 10% discount rate, 3% growth after year ten, starting from trailing twelve months free cash flow of $1.44B. Inputs: FMP statements, estimates and quote.
How the stock reacts to earnings
EPS beat in 8 of the last 12 reports (2024–2026); the stock still fell the next session after 2 of those beats. Average first-session move: 3.6% either way.
- +4.7%Feb ’24
- +4.1%May ’24
- +0.7%Jul ’24
- +0.2%Nov ’24
- +4.7%Feb ’25
- -0.2%Apr ’25
- -5.2%Jul ’25
- +3.2%Nov ’25
- -5.7%Feb ’26
- +1.8%May ’26
- +3.8%Aug ’26
- +9.1%Nov ’26
Every report, with revenue and five-session moves
| Report | EPS | Revenue | Next session | 5 sessions |
|---|---|---|---|---|
| Beat | Beat | +9.1% | +6.4% | |
| Beat | Beat | +3.8% | +6.2% | |
| Beat | Beat | +1.8% | +3.1% | |
| Miss | Beat | -5.7% | -0.1% | |
| Beat | Beat | +3.2% | +24.7% | |
| Beat | Beat | -5.2% | -6.0% | |
| Beat | Miss | -0.2% | -5.7% | |
| Miss | Miss | +4.7% | +9.0% | |
| Miss | In line | +0.2% | +8.4% | |
| Miss | Beat | +0.7% | -14.5% | |
| Beat | Beat | +4.1% | +8.4% | |
| Beat | Beat | +4.7% | +5.3% |
The market has been forgiving after misses, which says investors are looking past the quarter to the longer story.
What management is saying differently
Management's own words on the Q3 FY2026 call () against Q2 FY2026 (). Analysts' questions are left out.
- New this call: “capital spending”, “specialties adjusted” — none of them came up in Q2 FY2026.
- Gone quiet: “stationary storage”, “bromine index”, “chain disruptions”, “outlook ranges” — regular themes last call, absent this time.
The tone held steady from one call to the next; what changed is the subject matter, not the confidence.
Our track record on this stock
Since the score went from 62 to 72 while the share price moved -41.4% through .
| Date | Band | 3 months | 6 months | Call |
|---|---|---|---|---|
| Fair → Strong | — | — | — |
The one band change we have recorded has not been graded yet; we grade each band change three months after it happens.
The crowd against our signals
- Analysts: 46% of 46 rate it a buy; the average target sits +98.7% from the price of $82.93.
- Last 90 days: 1 upgrade and 0 downgrades among 15 rating actions.
- Our signals: Strong band; strongest pillar Valuation (87), weakest Momentum (26).
Our signals are more constructive than the crowd, led by Valuation.
Price & events
Triangles mark reported quarters on the line: pointing up is above the recorded estimate, down is below, a diamond means no estimate on file or a dated event that is not a results report. Numbers key to the dated list. Point at or tab to any week for its close.
Events behind the price
- · Earnings results · below the recorded estimate
- · Earnings results · above the recorded estimate
- · Earnings results · above the recorded estimate
- · Earnings results · above the recorded estimate
- · Earnings call · management outlook
Results dates follow the earnings feed; call dates follow the transcript provider. Nearby dates do not establish that an event caused a price move.
Upcoming events
Management outlook
For the fourth quarter, we expect energy storage net sales and adjusted EBITDA to decrease sequentially, assuming today's lower market pricing persists for the remainder of the quarter, while volumes will be steady with the third quarter.
Neal Sheorey · Statement from
How to read these dates
Events are in date order; the spacing is not a duration scale. A statement's date is the earnings call where it was made, not a deadline. Management expectations and estimated dates can change.
Other perspectives
Council score for Albemarle (ALB): perspectives
Council is a separate blend of available disciplines; MoonshotScore above remains the five-pillar research rating.
5-Factor Breakdown
Legends Council
6 lenses, 0 current
AI simulations built from the named investors' published principles. Not affiliated with, endorsed by, or the opinion of these individuals. How these lenses are built
Read on: Nov 18, 2026 · older than the 27 hours refresh window; not a current reading
Munger's Mindset
Balance Sheet & Valuation
Read on: Nov 21, 2026
How to read these bars and different assessments
Council is a separate blend of available disciplines; MoonshotScore above remains the five-pillar research rating.
Bars show each model's ordered assessment on its own scale, not a probability or a comparable investment return. The adjacent words give the assessment; more filled segments indicate a stronger model reading.
The Munger lens reads the current price as undervalued against its own estimate of value.
Readings on this page are from Nov 21, 2026, except a card that shows its own read date.
What is Albemarle (ALB), and what does it report?
Short answer · as of
Albemarle sells chemical inputs rather than finished electric vehicles or batteries.
Research dated 2026-09-13 (results through the quarter ended Jun 2026; the quarter ended Sep 2026 not covered).
Lithium carbonate, hydroxide, chloride and related products feed battery manufacturing as well as greases, elastomers, pharmaceuticals and chemical synthesis; bromine products serve fire safety, drilling, emissions control, water purification and processing, while catalysts serve refiners and chemical producers.
Business descriptions group operations under Lithium, Bromine and Catalysts, while revenue is presented as Energy Storage, Specialties and Ketjen. Energy Storage is the largest revenue line, so consolidated results carry greater battery-material exposure than an evenly balanced specialty-chemicals portfolio would suggest.
What do the latest results show for Albemarle (ALB)?
Research dated 2026-09-13 (results through the quarter ended Jun 2026; the quarter ended Sep 2026 not covered).
Recent results show a sharp improvement: revenue increased, gross and operating profit expanded faster, net income moved firmly positive, and diluted earnings strengthened. Revenue and reported earnings also cleared market expectations after earlier mixed comparisons.
The immediate earnings mechanism is visible in the income statement: higher sales produced a disproportionately larger increase in gross profit, which then flowed into operating profit. Cash conversion strengthened alongside it, as operating cash flow rose materially while capital spending fell.
Management has drawn a boundary around that momentum by expecting net sales and EBITDA to decline sequentially in the coming period. The latest acceleration therefore sets a demanding comparison rather than an established run rate.
Where is operating spending going?
Revenue alongside research and development, selling, general and administrative expenses, and the FMP standardized operating result.
- Latest quarter · revenue
- $1.55B Sep 30, 2026
- Latest quarter · R&D
- $8.17M Sep 30, 2026
- Latest quarter · SG&A
- $136.35M Sep 30, 2026
- Latest quarter · FMP standardized operating result
- $148.16M Sep 30, 2026
| Period end | Revenue | R&D | SG&A | FMP standardized operating result |
|---|---|---|---|---|
| Sep 30, 2026 | $1.55B | $8.17M | $136.35M | $148.16M |
| Jun 30, 2026 | $1.74B | $3.67M | $126.35M | $452.94M |
| Mar 31, 2026 | $1.43B | $9.17M | $137.41M | $233.51M |
| Dec 31, 2025 | $1.43B | $12.18M | $142.30M | $48.25M |
How to read these figures
Amounts are in US dollars. The operating result is Financial Modeling Prep’s standardized figure, so it can differ from the operating line in the company’s filing. It is not net income or cash flow.
Did results meet expectations?
Reported earnings and revenue alongside the estimates recorded by the provider.
- Latest report · revenue
- $1.55B Nov 4, 2026
- Latest report · revenue estimate
- $1.52B Nov 4, 2026
- Latest report · revenue vs estimate
- Above estimate Nov 4, 2026
- Latest report · EPS vs estimate
- Above estimate Nov 4, 2026
| Report date | Revenue · reported | Revenue · estimate | EPS · reported | EPS · estimate |
|---|---|---|---|---|
| Nov 4, 2026 | $1.55B | $1.52B | $2.5800 | $2.5300 |
| Aug 5, 2026 | $1.74B | $1.61B | $3.7500 | $3.2000 |
| May 6, 2026 | $1.43B | $1.34B | $2.9500 | $1.1900 |
| Feb 11, 2026 | $1.43B | $1.35B | −$0.5300 | −$0.4178 |
How to read these figures
Dates are when results were reported, not quarter ends. Amounts are in US dollars; EPS is per share. The source does not say whether EPS is basic, diluted or adjusted, so it can differ from the EPS in the income statement.
Quarterly income statement — 4 quarters
| Period | Revenue | Net income | EPS |
|---|---|---|---|
| Sep 2026 | $1.55B | $297M | $2.15 (diluted) |
| Jun 2026 | $1.74B | $480M | $3.22 (diluted) |
| Mar 2026 | $1.43B | $319M | $2.34 (diluted) |
| Dec 2025 | $1.43B | -$414M | -$3.87 (diluted) |
What are the financial strengths and risks for Albemarle (ALB)?
Short answer
Cash and short-term investments were $1.85B at the Sep 30, 2026 balance-sheet date. Operating cash flow was $405.80M for the quarter ended Sep 30, 2026, meaning operations generated cash. These figures do not establish a cash runway.
Research dated 2026-09-13 (results through the quarter ended Jun 2026; the quarter ended Sep 2026 not covered).
Liquidity is serviceable but not debt-free. Cash and short-term investments remain below total debt, while the broader cash-and-investment total exceeds debt after including long-term investments; the current and quick liquidity measures also remain above their coverage thresholds.
Cash and short-term investments ended close to their opening level across the reported window despite sizable period-to-period swings, and recent operating cash flow exceeded capital spending by a wide margin. The central financial risk is concentration: Energy Storage supplies the largest share of revenue, while the annual record shows how rapidly a severe sales contraction can carry the company into losses.
Recent cash generation provides flexibility, but trailing returns remain modest and the earnings multiple rests on a profit base still recovering from annual losses.
How much cash does the business generate or use?
Quarterly operating cash flow shows cash generated or used by operations.
- Latest quarter · operating cash flow
- $405.80M Sep 30, 2026
- Previous quarter · operating cash flow
- $710.00M Jun 30, 2026
| Period end | Operating cash flow | Capital expenditure (reported) |
|---|---|---|
| Sep 30, 2026 | $405.80M | −$80.37M |
| Jun 30, 2026 | $710.00M | −$71.73M |
| Mar 31, 2026 | $346.24M | −$98.68M |
| Dec 31, 2025 | $388.49M | −$155.38M |
How to read these figures
Amounts are in US dollars. Negative operating cash flow means the business used cash. Capital spending is shown as reported; we do not combine it into a free-cash-flow or runway estimate. The bars share one scale.
What should you watch next at Albemarle (ALB)?
Short answer · as of
The next earnings report is expected on Feb 10, 2027. The number it tests is the $10.70 EPS analysts carry for it.
Research dated 2026-09-13 (results through the quarter ended Jun 2026; the quarter ended Sep 2026 not covered).
Management’s sequential decline call sets the immediate test. Watch whether net sales and EBITDA retreat as indicated, whether gross and operating profit surrender much of their recent improvement, and whether reported earnings continue to clear expectations when the scheduled release arrives.
Cash deserves an equal place on the checklist: compare operating cash flow with capital spending, then follow the movement in cash and short-term investments. Another wide cash surplus would reinforce the earnings recovery; renewed cash draw alongside weaker sales would expose its fragility.
Longer-range analyst revenue estimates carry a wide spread, making changes in the range more informative than the average alone.
What management is planning
How does Albemarle compare with its peers?
Short answer
Albemarle's score ranks 2nd of 7 in the bounded comparison shown, against 6 same-model peers. These are company scores, not expected investment returns. The set lists named competitors first, then companies in the same data-provider industry classification closest in market value; that classification is the provider's, not our judgment of business similarity.
Research dated 2026-09-13 (results through the quarter ended Jun 2026; the quarter ended Sep 2026 not covered).
Albemarle combines a battery-material franchise with bromine specialties and refinery catalysts; it is not a conventional specialty-chemicals portfolio with evenly distributed exposure across unrelated niches. Energy Storage is already the largest line, while the remaining portfolio connects results to fire safety, drilling, emissions control, water purification, chemical processing and refining.
That mix creates a distinct comparison lens. Chemical manufacturing breadth remains, but consolidated performance can swing with lithium-led Energy Storage, as the annual revenue and profit reversal followed by the recent quarterly recovery demonstrates.
| Company | Price | Market value | Score |
|---|---|---|---|
| $231.52 Nov 19, 2026 | $19.6B | 97 5-pillar Nov 18, 2026 | |
| Albemarle (ALB) — this page | $82.93 | $9.79B | 72 |
| $34.88 Nov 19, 2026 | $7.47B | 69 5-pillar Nov 18, 2026 | |
| $58.19 Nov 19, 2026 | $18.8B | 67 5-pillar Nov 18, 2026 | |
| $47.85 Nov 19, 2026 | $13.7B | 61 5-pillar Nov 18, 2026 | |
| $59.23 Nov 19, 2026 | $7.57B | 47 5-pillar Nov 18, 2026 | |
| $149.69 Nov 19, 2026 | $19.8B | 43 5-pillar Nov 18, 2026 |
Only 5-pillar scores are ranked together. Other models are not directly comparable. Price and score dates are shown separately; market-value dates are unavailable.
The records behind this page
Analyst targets & estimates
What analysts have on file
- Price target, low to high
- $109.00 – $224.00
- Consensus target
- $151.58
- Median target
- $142.50
- Revenue estimate
- $6.10B
- EPS estimate
- $10.70
Consensus record · Captured .
Measured against a quoted price of $82.93 (as of Nov 19, 2026).
Insider activity
Form 4 records via FMP · Of the newest 60 records, those within the last 180 days, newest dated Nov 16, 2026
- Transactions
- 25
- Identified insiders
- 16
- Purchases
- 0
- Sales
- 0
- Other transactions
- 25
Purchases and sales use the reported transaction category. Other transactions include awards, exercises, gifts, withholding and unclassified activity; an acquisition or disposition alone is not a purchase or sale. These records do not establish intent.
Who holds the shares?
Institutional ownership reported through 13F filings.
- Institutional ownership
- 96.8% Period end Sep 30, 2026
- Previous quarter · ownership
- 99.0% Prior to period end Sep 30, 2026
- Reporting holders
- 924 Period end Sep 30, 2026
- Previous quarter · holders
- 1,032 Prior to period end Sep 30, 2026
| Holders in provider snapshot | Shares |
|---|---|
| Blackrock, INC. | 10,028,621 |
| Capital World Investors | 9,650,053 |
| Vanguard Capital Management LLC | 7,735,005 |
| Vanguard Portfolio Management LLC | 6,456,433 |
| State Street Corp | 6,323,318 |
Tracked investors
Which of the 16 named investors we follow held ALB in their latest 13F filing, and what they did against the filing before it.
| Investor | Manager | 13F quarter | Portfolio weight | Value | Last quarter |
|---|---|---|---|---|---|
| Bridgewater Associates | Founded by Ray Dalio | Q3 2026 | 0.04% | $9.87M | Trimmed −19.7% shares |
How to read these figures
These filings arrive after the quarter ends. Names appear as the provider lists them, not as a verified ranking, and without filing dates. Related managers can appear separately, so their shares are not added together. Holder snapshot as of Sep 30, 2026. Tracked investors: each fund's own latest 13F, so funds that have not filed the newest quarter yet show their previous one; weight is the share of the fund's reported 13F value.
What Investors Ask About Albemarle (ALB) — Basic Materials
Research dated 2026-09-13 (results through the quarter ended Jun 2026; the quarter ended Sep 2026 not covered); the full attribution is under Sources. The last 2 questions are answered from this page's own dated data, not from the research.
What does Albemarle sell to battery manufacturers?
Albemarle supplies lithium compounds including carbonate, hydroxide and chloride for battery production. Battery exposure sits within Energy Storage, the company’s largest reported revenue segment.
Why is Albemarle’s Energy Storage segment so important?
Energy Storage contributes more revenue than any other reported segment, giving lithium-related demand an outsized influence on consolidated performance. The company’s sharp annual reversal and recent quarterly recovery show the financial sensitivity attached to that concentration.
How do Albemarle’s businesses outside Energy Storage broaden its end markets?
Bromine-based products reach fire safety, drilling, emissions control, water purification and processing applications, while catalysts serve petroleum refiners and chemical producers. Those activities diversify the customer base without displacing Energy Storage as the largest revenue source.
What does Albemarle’s lower sequential sales and EBITDA outlook imply?
Management expects the recent sales momentum to reverse in the coming period. The durability of gross profit, operating profit and cash generation during that retreat will indicate whether the recovery extends beyond revenue growth.
What is the ALB stock price today?
The last price recorded for Albemarle Corporation (ALB), with its trading session and source, is listed under Price & valuation on this page. It is a provider snapshot, not a live exchange feed, so check a brokerage quote before you trade.
What is the ALB price target?
The analyst consensus price target for Albemarle Corporation (ALB), with its range and the date it was captured from FMP, is listed under Analyst targets & estimates on this page. Targets are analyst opinions and change often; they are not a Stock Expert AI forecast.
Research written by Codex (gpt-5.6-sol) on 2026-09-13. AI-authored analysis; source dates are listed under Sources. Editorial oversight is systemic, not page-by-page. Editorially accountable: Sedat ANAK, Founder and Editor-in-Chief.
Sources: the source register lists the 84 figures on this page — 2 from SEC filings and earnings calls, 70 from Financial Modeling Prep (FMP), 6 with no recorded source, 5 computed by us, formula shown in the register and 1 from Stock Expert AI's own score and rank. Its rows (value as shown, as-of date, tier and source link) are in the Markdown version of this page.
Publication details and research sources
- Published
- Research standards
- Methodology · Editorial policy · Corrections
- Report a number
- sedat@stockexpertai.com
Sources (as of 2026-09-13), by section of the research
ETFs that hold ALB
Funds in our ETF coverage that list ALB among the top 10 holdings on their fund page, largest weight first. Each weight is the fund's reported holding weight as of the date in its row.
| ETF | Weight | Holdings as of |
|---|---|---|
| First Trust NASDAQ Clean Edge Green Energy Index Fund (QCLN) | 5.00% | |
| Sprott Critical Materials ETF (SETM) | 4.58% |
